Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Nivolumab for the Treatment of Advanced Pediatric Malignancies

AGATA MARJAŃSKA, MONIKA DROGOSIEWICZ, BOŻENNA DEMBOWSKA-BAGIŃSKA, KATARZYNA PAWIŃSKA-WĄSIKOWSKA, WALENTYNA BALWIERZ, KATARZYNA BOBEFF, WOJCIECH MŁYNARSKI, AGNIESZKA MIZIA-MALARZ, ANNA RACIBORSKA, MARIUSZ WYSOCKI and JAN STYCZYŃSKI
Anticancer Research December 2020, 40 (12) 7095-7100; DOI: https://doi.org/10.21873/anticanres.14738
AGATA MARJAŃSKA
1Department of Pediatric, Hematology and Oncology, Nicolaus Copernicus University Torun, Jurasz University Hospital, Collegium Medicum, Bydgoszcz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: agata.marjanska{at}wp.pl
MONIKA DROGOSIEWICZ
2Department of Oncology, The Children’s Memorial Health Institute, Warsaw, Poland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BOŻENNA DEMBOWSKA-BAGIŃSKA
2Department of Oncology, The Children’s Memorial Health Institute, Warsaw, Poland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KATARZYNA PAWIŃSKA-WĄSIKOWSKA
3Department of Pediatric, Oncology and Hematology, Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WALENTYNA BALWIERZ
3Department of Pediatric, Oncology and Hematology, Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KATARZYNA BOBEFF
4Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Lodz, Poland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WOJCIECH MŁYNARSKI
4Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Lodz, Poland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AGNIESZKA MIZIA-MALARZ
5Department of Pediatric, Oncology, Hematology and Chemotherapy, Upper Silesia Children’s Care Health Centre, Medical University of Silesia, Katowice, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANNA RACIBORSKA
6Department of Oncology and Surgical Oncology for Children and Youth, Institute of Mother and Child, Warsaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARIUSZ WYSOCKI
1Department of Pediatric, Hematology and Oncology, Nicolaus Copernicus University Torun, Jurasz University Hospital, Collegium Medicum, Bydgoszcz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JAN STYCZYŃSKI
1Department of Pediatric, Hematology and Oncology, Nicolaus Copernicus University Torun, Jurasz University Hospital, Collegium Medicum, Bydgoszcz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 40 no. 12 7095-7100
DOI 
https://doi.org/10.21873/anticanres.14738
PMID 
33288608

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received October 7, 2020
  • Revision received October 26, 2020
  • Accepted October 30, 2020
  • Published online December 7, 2020.

Copyright & Usage 
Copyright © 2020 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. AGATA MARJAŃSKA⇑*,1,
  2. MONIKA DROGOSIEWICZ*,2,
  3. BOŻENNA DEMBOWSKA-BAGIŃSKA2,
  4. KATARZYNA PAWIŃSKA-WĄSIKOWSKA3,
  5. WALENTYNA BALWIERZ3,
  6. KATARZYNA BOBEFF4,
  7. WOJCIECH MŁYNARSKI4,
  8. AGNIESZKA MIZIA-MALARZ5,
  9. ANNA RACIBORSKA6,
  10. MARIUSZ WYSOCKI1 and
  11. JAN STYCZYŃSKI1
  1. 1Department of Pediatric, Hematology and Oncology, Nicolaus Copernicus University Torun, Jurasz University Hospital, Collegium Medicum, Bydgoszcz, Poland
  2. 2Department of Oncology, The Children’s Memorial Health Institute, Warsaw, Poland;
  3. 3Department of Pediatric, Oncology and Hematology, Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland
  4. 4Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Lodz, Poland;
  5. 5Department of Pediatric, Oncology, Hematology and Chemotherapy, Upper Silesia Children’s Care Health Centre, Medical University of Silesia, Katowice, Poland
  6. 6Department of Oncology and Surgical Oncology for Children and Youth, Institute of Mother and Child, Warsaw, Poland
  1. Correspondence to: Agata Marjańska, MD, Department of Pediatric Hematology and Oncology, Collegium Medicum, Nicolaus Copernicus University, Antoni Jurasz University Hospital No. 1, ul. Sklodowskiej-Curie 9, 85-094 Bydgoszcz, Poland. Tel: +48 525854860, Fax: +48 525854087, e-mail: agata.marjanska{at}wp.pl
View Full Text

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 40, Issue 12
December 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Nivolumab for the Treatment of Advanced Pediatric Malignancies
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Nivolumab for the Treatment of Advanced Pediatric Malignancies
AGATA MARJAŃSKA, MONIKA DROGOSIEWICZ, BOŻENNA DEMBOWSKA-BAGIŃSKA, KATARZYNA PAWIŃSKA-WĄSIKOWSKA, WALENTYNA BALWIERZ, KATARZYNA BOBEFF, WOJCIECH MŁYNARSKI, AGNIESZKA MIZIA-MALARZ, ANNA RACIBORSKA, MARIUSZ WYSOCKI, JAN STYCZYŃSKI
Anticancer Research Dec 2020, 40 (12) 7095-7100; DOI: 10.21873/anticanres.14738

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Nivolumab for the Treatment of Advanced Pediatric Malignancies
AGATA MARJAŃSKA, MONIKA DROGOSIEWICZ, BOŻENNA DEMBOWSKA-BAGIŃSKA, KATARZYNA PAWIŃSKA-WĄSIKOWSKA, WALENTYNA BALWIERZ, KATARZYNA BOBEFF, WOJCIECH MŁYNARSKI, AGNIESZKA MIZIA-MALARZ, ANNA RACIBORSKA, MARIUSZ WYSOCKI, JAN STYCZYŃSKI
Anticancer Research Dec 2020, 40 (12) 7095-7100; DOI: 10.21873/anticanres.14738
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • T-cell-based Immunotherapies for Haematological Cancers, Part A: A SWOT Analysis of Immune Checkpoint Inhibitors (ICIs) and Bispecific T-Cell Engagers (BiTEs)
  • Google Scholar

More in this TOC Section

  • Efficacy and Safety of Oral 5-FU Derivatives After Progression of HR+/HER2− Metastatic Breast Cancer on CDK4/6 Inhibitor
  • Postoperative Complications, Including Minor Complications, Worsen Prognosis After Laparoscopic Distal Gastrectomy for Gastric Cancer
  • Impact of Emphysema Severity on Clinicopathological and Molecular Features in Non–small Cell Lung Cancer
Show more Clinical Studies

Keywords

  • nivolumab
  • ipilimumab
  • anti-PD-1
  • pediatric cancer
  • malignant melanoma
  • brain tumor
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire